Ultrasound Molecular Imaging of Renal Cell Carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles

Recent treatment developments for metastatic renal cell carcinoma offer combinations of immunotherapies or immunotherapy associated with tyrosine kinase inhibitors (TKI). There is currently no argument to choose one solution or another. Easy-to-use markers to assess longitudinal responses to TKI are...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingels, Alexandre, Leguerney, Ingrid, Cournède, Paul-Henry, Irani, Jacques, Ferlicot, Sophie, Sébrié, Catherine, Benatsou, Baya, Jourdain, Laurène, Pitre-Champagnat, Stephanie, Patard, Jean-Jacques, Lassau, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193565/
https://www.ncbi.nlm.nih.gov/pubmed/32355171
http://dx.doi.org/10.1038/s41598-020-64433-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193565/
https://www.ncbi.nlm.nih.gov/pubmed/32355171
http://dx.doi.org/10.1038/s41598-020-64433-2

Ejemplares similares